Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

8.365
+0.0650.78%
Volume:2.13M
Turnover:17.73M
Market Cap:8.80B
PE:-19.35
High:8.510
Open:8.295
Low:8.135
Close:8.300
52wk High:19.860
52wk Low:7.950
Shares:1.05B
HK Float Shares:1.05B
Volume Ratio:1.84
T/O Rate:0.20%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.432
ROE:-28.59%
ROA:-19.64%
PB:3.32
PE(LYR):-19.35
PS:7956.53

Loading ...

Ascletis Announces U.S. FDA Ind Clearance for Phase I Study of Once-Monthly Subcutaneously Administered Glp-1R/Gipr Dual Peptide Agonist, Asc35, for the Treatment of Obesity

THOMSON REUTERS
·
Jun 23

Ascletis wins US FDA IND clearance for Phase I study of monthly obesity drug ASC35

Reuters
·
Jun 23

Ascletis Pharma - Receives U.S. FDA Ind Clearance for Phase I Study of Asc35 for Obesity

THOMSON REUTERS
·
Jun 23

HK Movers | Biotech Stocks Jump. InnoGen up over 17%; Alphamab, Hengrui Pharma, Laekna, Keymed Bio up Around 5%; Joinn, Remegen up About 4%

Tiger Newspress
·
Jun 23

ASCLETIS-B Executes Share Buyback on June 22, Spending HK$1.901 Million

Stock News
·
Jun 22

Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation

Reuters
·
Jun 22

ASCLETIS-B Executes Share Buyback Totaling HK$1.97 Million

Stock News
·
Jun 17

Ascletis Pharma files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 17

ASCLETIS-B Executes Share Buyback, Spending HK$1.86 Million

Stock News
·
Jun 16

Ascletis Pharma files HKEX next-day disclosure return reporting share repurchase for cancellation

Reuters
·
Jun 16

ASCLETIS-B Executes Share Buyback, Spending HK$1,918,300 on June 15

Stock News
·
Jun 15

Ascletis Pharma files HKEX next-day return disclosing share repurchase for cancellation

Reuters
·
Jun 15

One Ascletis Pharma Insider Has Reduced Their Stake

Simply Wall St.
·
Jun 13

Ascletis Pharma launches fresh HKD 1.97 million buyback; cumulative repurchases reach 7.89 million shares

Bulletin Express
·
Jun 11

ASCLETIS-B Executes HK$1.97 Million Share Buyback on June 11

Stock News
·
Jun 11

Ascletis Pharma Executes HKD 2.00 Million Share Buyback; Cumulative Repurchases Reach 7.69 Million Shares

Bulletin Express
·
Jun 10

ASCLETIS-B Executes Share Buyback, Spending Nearly HK$2 Million

Stock News
·
Jun 10

Ascletis Pharma Carries Out HKD 2.01 Million Share Buyback; Cumulative Repurchases Climb to 7.49 Million Shares

Bulletin Express
·
Jun 09

Ascletis Pharma repurchases 200,000 shares at HK$9.88–10.26; cumulative buy-backs under mandate rise to 7.29 million

Bulletin Express
·
Jun 08

ASCLETIS-B Executes Share Buyback, Spending HK$2 Million on June 8

Stock News
·
Jun 08